Cargando…
Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway
Cervical carcinoma (CC) is the second most prevalent gynecologic cancer in females across the world. To obtain a better understanding of the mechanisms underlying the development of CC, high-resolution label-free mass spectrometry was performed on CC and adjacent normal tissues from eight patients....
Autores principales: | Hu, Wei, Hu, Yaorui, Pei, Yao, Li, Rongrong, Xu, Fuyi, Chi, Xiaodong, Mi, Jia, Bergquist, Jonas, Lu, Lu, Zhang, Luping, Yang, Chunhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821498/ https://www.ncbi.nlm.nih.gov/pubmed/36614304 http://dx.doi.org/10.3390/ijms24010861 |
Ejemplares similares
-
Silencing c-Jun inhibits autophagy and abrogates radioresistance in nasopharyngeal carcinoma by activating the PI3K/AKT/mTOR pathway
por: Sun, Yongchu, et al.
Publicado: (2021) -
PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011) -
Neuroinflammation and central PI3K/Akt/mTOR signal pathway contribute
to bone cancer pain
por: Zhang, Jian, et al.
Publicado: (2019) -
Targeting PI3K/Akt/mTOR Signaling in Cancer
por: Porta, Camillo, et al.
Publicado: (2014) -
PI3K/Akt/mTOR inhibitors in breast cancer
por: Lee, Joycelyn JX, et al.
Publicado: (2015)